Chemours (CC) Tops Q4 EPS by 6c, FY EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
The Chemours Company Reports Fourth Quarter and Full Year 2018 Results
February 14, 2019 4:15 PM ESTWILMINGTON, Del., Feb. 14, 2019 /PRNewswire/ --
Full Year 2018 Highlights
Net Sales of $6.6 billion, up 7% Net Income of $995 million, up 33%, with EPS of $5.45, up 39% Adjusted Net Income of $1.0 billion, up 42%, with Adjusted EPS of $5.67, up 48% Adjusted EBITDA of $1.7 billion, up 22% Returned over $790 million to shareholders through share repurchases and dividendsFourth Quarter 2018 Highlights
Net Sales of $1.5 billion Net Income of $142 million with EPS of $0.81 Adjusted Net Income of $185 million, with Adjusted EPS of $1.05 Adjusted EBITDA of $341 millionOther... More
